These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 38609160)
1. Depression, Anxiety, and Risk of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Longitudinal Study. Lee IT; Rees J; King S; Kim A; Cherlin T; Hinkle S; Mumford SL; Dokras A J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38609160 [TBL] [Abstract][Full Text] [Related]
2. Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study. Lee I; Vresilovic J; Irfan M; Gallop R; Dokras A J Clin Endocrinol Metab; 2022 Mar; 107(4):e1558-e1567. PubMed ID: 34928388 [TBL] [Abstract][Full Text] [Related]
3. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome. Feldman RA; O'Neill K; Butts SF; Dokras A Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995 [TBL] [Abstract][Full Text] [Related]
4. Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected]. Hillman JK; Johnson LN; Limaye M; Feldman RA; Sammel M; Dokras A Fertil Steril; 2014 Feb; 101(2):530-5. PubMed ID: 24382375 [TBL] [Abstract][Full Text] [Related]
5. Women with polycystic ovary syndrome associated with increased anxiety risk: A population-based cohort study in Taiwan. Harnod T; Tsai IJ; Wang JH; Lin SZ; Ding DD J Affect Disord; 2020 Aug; 273():532-537. PubMed ID: 32560950 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Cooney LG; Lee I; Sammel MD; Dokras A Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286 [TBL] [Abstract][Full Text] [Related]
7. Association between depression risk and polycystic ovarian syndrome in young women: a retrospective nationwide population-based cohort study (1998-2013). Harnod T; Chen W; Wang JH; Lin SZ; Ding DC Hum Reprod; 2019 Sep; 34(9):1830-1837. PubMed ID: 31407777 [TBL] [Abstract][Full Text] [Related]
8. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis. Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R Elife; 2023 Aug; 12():. PubMed ID: 37534878 [TBL] [Abstract][Full Text] [Related]
9. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Dokras A; Stener-Victorin E; Yildiz BO; Li R; Ottey S; Shah D; Epperson N; Teede H Fertil Steril; 2018 May; 109(5):888-899. PubMed ID: 29778388 [TBL] [Abstract][Full Text] [Related]
10. Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden. Elenis E; Desroziers E; Persson S; Sundström Poromaa I; Campbell RE Hum Reprod; 2021 Apr; 36(5):1427-1435. PubMed ID: 33454768 [TBL] [Abstract][Full Text] [Related]
11. Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome. Jannink T; Bordewijk EM; Aalberts J; Hendriks J; Lehmann V; Hoek A; Goddijn M; van Wely M; Hum Reprod; 2024 Apr; 39(4):784-791. PubMed ID: 38335234 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years. Fernandez RC; Moore VM; Rumbold AR; Whitrow MJ; Avery JC; Davies MJ Hum Reprod; 2021 Jul; 36(8):2275-2284. PubMed ID: 33963388 [TBL] [Abstract][Full Text] [Related]